Circulating MicroRNA-21 is a potential diagnostic biomarker in gastric cancer

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Wu, Jianhong ^a   Li, Guangxin ^b   Wang, Zeyou ^c   Yao, Yongliang ^a   Chen, Rui ^b   Pu, Xiongyong ^a   Wang, Jianjun ^a  

^a JIANGSU UNIVERSITY   (China)

^b Chongqing Cancer Institute   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CA 199 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; MICRORNA 21; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG; CARBOHYDRATE ANTIGEN 199, HUMAN; MICRORNA; MIRN21 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; BLOOD; GENETICS; METABOLISM; PATHOLOGY; STOMACH TUMOR;

ADULT; AGED; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BIOMARKERS, TUMOR; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 84929631025     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/435656     Document Type: Article

References (45)

1. B. C. Schanen and X. Li, "Transcriptional regulation of mammalian miRNA genes, " Genomics, vol. 97, no. 1, pp. 1-6, 2011.
2. M. Lagos-Quintana, R. Rauhut, W. Lendeckel, and T. Tuschl, "Identification of novel genes coding for small expressedRNAs, " Science, vol. 294, no. 5543, pp. 853-858, 2001.
3. D. Sayed and M. Abdellatif, "Micrornas in development and disease, " Physiological Reviews, vol. 91, no. 3, pp. 827-887, 2011.
4. J. Krol, I. Loedige, and W. Filipowicz, "The widespread regulation of microRNA biogenesis, function and decay, " Nature Reviews Genetics, vol. 11, no. 9, pp. 597-610, 2010.
5. S. K. Shenouda and S. K. Alahari, "MicroRNA function in cancer: oncogene or a tumor suppressor?" Cancer and Metastasis Reviews, vol. 28, no. 3-4, pp. 369-378, 2009.
6. E. Tili, J.-J. Michaille, V. Gandhi, W. Plunkett, D. Sampath, and G. A. Calin, "MiRNAs and their potential for use against cancer and other diseases, " Future Oncology, vol. 3, no. 5, pp. 521-537, 2007.
7. W. C. S. Cho, "OncomiRs: the discovery and progress of microRNAs in cancers, " Molecular Cancer, vol. 6, no. 1, article 60, 2007.
8. F. Meng, R. Henson, H. Wehbe-Janek, K. Ghoshal, S. T. Jacob, and T. Patel, "MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer, " Gastroenterology, vol. 133, no. 2, pp. 647-658, 2007.
9. T. Papagiannakopoulos, A. Shapiro, and K. S. Kosik, "MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells, " Cancer Research, vol. 68, no. 19, pp. 8164-8172, 2008.
10. G. Gabriely, T. Wurdinger, S. Kesari et al., "MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators, " Molecular and Cellular Biology, vol. 28, no. 17, pp. 5369-5380, 2008.
11. M. Liu, H. Wu, T. Liu et al., "Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma, " Cell Research, vol. 19, no. 7, pp. 828-837, 2009.
12. T. X. Lu, A. Munitz, and M. E. Rothenberg, "MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression, " Journal of Immunology, vol. 182, no. 8, pp. 4994-5002, 2009.
13. S. T. Hashimi, J. A. Fulcher, M. H. Chang, L. Gov, S. Wang, and B. Lee, "MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 andWNT1 in the coordinate regulation of dendritic cell differentiation, " Blood, vol. 114, no. 2, pp. 404-414, 2009.
14. J. Zheng, H. Xue, T. Wang et al., "miR-21 downregulates the tumor suppressor P12 CDK2AP1 and stimulates cell proliferation and invasion, " Journal of Cellular Biochemistry, vol. 112, no. 3, pp. 872-880, 2011.
15. K. Wu, L. Li, and S. Li, "Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies, " Tumor Biology, vol. 36, no. 3, pp. 1973-1981, 2015.
16. J. A. Chan, A. M. Krichevsky, and K. S. Kosik, "MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells, " Cancer Research, vol. 65, no. 14, pp. 6029-6033, 2005.
17. S. Volinia, G. A. Calin, C.-G. Liu et al., "A microRNA expression signature of human solid tumors defines cancer gene targets, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257-2261, 2006.
18. A. Feber, L. Xi, J. D. Luketich et al., "MicroRNA expression profiles of esophageal cancer, " The Journal of Thoracic and Cardiovascular Surgery, vol. 135, no. 2, pp. 255-260, 2008.
19. O. Slaby, M. Svoboda, P. Fabian et al., "Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer, " Oncology, vol. 72, no. 5-6, pp. 397-402, 2008.
20. E. J. Nam, H. Yoon, S. W. Kim et al., "MicroRNA expression profiles in serous ovarian carcinoma, " Clinical Cancer Research, vol. 14, no. 9, pp. 2690-2695, 2008.
21. M. V. Iorio, M. Ferracin, C.-G. Liu et al., "MicroRNA gene expression deregulation in human breast cancer, " Cancer Research, vol. 65, no. 16, pp. 7065-7070, 2005.
22. W.-O. Lui, N. Pourmand, B. K. Patterson, and A. Fire, "Patterns of known and novel small RNAs in human cervical cancer, " Cancer Research, vol. 67, no. 13, pp. 6031-6043, 2007.
23. Y. Toiyama, M. Takahashi, K. Hur et al., "Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer, " Journal of the National Cancer Institute, vol. 105, no. 12, pp. 849-859, 2013.
24. A. J. Schetter, S. Y. Leung, J. J. Sohnet al., "MicroRNAexpression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma, " The Journal of the American Medical Association, vol. 299, no. 4, pp. 425-436, 2008.
25. X. Yang, Y. Guo, Y. Du et al., "Serum microRNA-21 as a diagnostic marker for lung carcinoma: a systematic review and meta-analysis, " PLoS ONE, vol. 9, no. 5, Article IDe97460, 2014.
26. Z. Zhang, Z. Li, C. Gao et al., "MiR-21 plays a pivotal role in gastric cancer pathogenesis and progression, " Laboratory Investigation, vol. 88, no. 12, pp. 1358-1366, 2008.
27. B. G. Zhang, J. F. Li, B. Q. Yu, Z. G. Zhu, B. Y. Liu, and M. Yan, "microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN, " Oncology Reports, vol. 27, no. 4, pp. 1019-1026, 2012.
28. W. M. Association, "Declaration of Helsinki, ethical principles for medical research involving human subjects, " in Proceedings of the 52ndWMAGeneral Assembly, Edinburgh, Scotland, 2000.
29. K. Iriyama, T. Asakawa, H. Koike, H. Nishiwaki, and H. Suzuki, "Is extensive lymphadenectomy necessary for surgical treatment of intramucosal carcinoma of the stomach?" Archives of Surgery, vol. 124, no. 3, pp. 309-311, 1989.
30. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, "Global cancer statistics, " CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69-90, 2011.
31. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, "Estimates of worldwide burden of cancer in 2008: GLOBOCAN2008, " International Journal ofCancer, vol. 127, no. 12, pp. 2893-2917, 2010.
32. M. P. A. Ebert and C. Röcken, "Molecular screening of gastric cancer by proteome analysis, " European Journal of Gastroenterology and Hepatology, vol. 18, no. 8, pp. 847-853, 2006.
33. S. R. Singh and P. Rameshwar, MicroRNA in Development and in the Progression of Cancer, Springer, 2014.
34. M. Ferracin and L. Lupini, "MicroRNA expression profiling and its clinical impact in breast cancer, " in MicroRNAs: Key Regulators of Oncogenesis, pp. 355-367, Springer, 2014.
35. T. A. Farazi, J. I. Hoell, P. Morozov, and T. Tuschl, "MicroRNAs in human cancer, " in MicroRNA Cancer Regulation, vol. 774 of Advances in Experimental Medicine and Biology, pp. 1-20, Springer, Amsterdam, The Netherlands, 2013.
36. S. S. C. Chim, T. K. F. Shing, E. C. W. Hung et al., "Detection and characterization of placental microRNAs in maternal plasma, " Clinical Chemistry, vol. 54, no. 3, pp. 482-490, 2008.
37. M. J. Lodes, M. Caraballo, D. Suciu, S. Munro, A. Kumar, and B. Anderson, "Detection of cancer with serum miRNAs on an oligonucleotide microarray, " PLoS ONE, vol. 4, no. 7, Article ID e6229, 2009.
38. G. M. Pasinetti, L. Ho, C. Dooley, B. Abbi, and G. Lange, "Select non-coding RNA in blood components provide novel clinically accessible biological surrogates for improved identification of traumatic brain injury inOEF/OIF Veterans, " American Journal of Neurodegenerative Disease, vol. 1, no. 1, pp. 88-98, 2012.
39. D.-J. Kim, S. Linnstaedt, J. Palma et al., "Plasma components affect accuracy of circulating cancer-related microRNA quantitation, " The Journal of Molecular Diagnostics, vol. 14, no. 1, pp. 71-80, 2012.
40. K. Wang, Y. Yuan, J.-H. Cho, S. McClarty, D. Baxter, and D. J. Galas, "Comparing the MicroRNA spectrum between serum and plasma, " PLoS ONE, vol. 7, no. 7, Article ID e41561, 2012.
41. S. Davis, S. Propp, S. M. Freier et al., "Potent inhibition of microRNA in vivo without degradation, " Nucleic Acids Research, vol. 37, no. 1, pp. 70-77, 2009.
42. J. S. Mcdonald, D. Milosevic, H. V. Reddi, S. K. Grebe, and A. Algeciras-Schimnich, "Analysis of circulating microRNA: preanalytical and analytical challenges, " Clinical Chemistry, vol. 57, no. 6, pp. 833-840, 2011.
43. W. Li and K. Ruan, "MicroRNA detection by microarray, " Analytical and Bioanalytical Chemistry, vol. 394, no. 4, pp. 1117-1124, 2009.
44. M. F. Corsten, R. Dennert, S. Jochems et al., "Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease, " Circulation: Cardiovascular Genetics, vol. 3, no. 6, pp. 499-506, 2010.
45. S. F. M. Haüsler, A. Keller, P. A. Chandran et al., "Whole bloodderived miRNA profiles as potential new tools for ovarian cancer screening, " British Journal of Cancer, vol. 103, no. 5, pp. 693-700, 2010.